Iron Status in BTM With Blood Transfusion
NCT04947540 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-07-19
Summary
To assess the possible role of iron overload as a cause of liver dysfunction in thalassemic childrens receiving multiple blood transfusion and its correlation with serum aminotransferases.
Conditions
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mohamed M Ghazally, professor · Egypt
Eligibility
- Min Age
- 5 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-07-31
- Primary Completion
- 2022-07-31
- Completion
- 2023-03-31
More Related Trials
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life and Treatment Satisfaction in β-Thalassemia Patients Receiving Deferasirox
NCT03358498 ·Status: UNKNOWN
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation
NCT00789516 ·Status: COMPLETED
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia Intermedia
NCT01443312 ·Status: COMPLETED
-
Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia
NCT03947632 ·Status: COMPLETED
-
Correlation Between Pulmonary Functions and Physical Fitness in Children With β-thalassemia
NCT05494333 ·Status: UNKNOWN
-
An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
NCT02173951 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Genes Influencing Iron Overload State
NCT01158794 ·Status: COMPLETED
-
Assessment of Cognitive Function, Fatigue and Health Related Quality of Life in Children With Beta Thalassemia
NCT05469230 ·Status: COMPLETED
-
Blood Transfusions in Thalassemia Patients, Complications and Adverse Effects
NCT00971880 ·Status: COMPLETED
-
Assessment of Quality of Life in Thalassemic Patients at Assiut University Hospital: A Single-center Experience
NCT05790980 ·Status: UNKNOWN
-
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients
NCT05355766 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 ·Status: COMPLETED
-
Thalassemia Treatment Based on the Stem Cell Technology
NCT03222453 ·Status: UNKNOWN ·Phase: NA
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia
NCT06743854 ·Status: NOT_YET_RECRUITING
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Reproductive Capacity and Iron Burden in Thalassemia
NCT02308904 ·Status: COMPLETED ·Phase: NA
-
Long-term Clinical Study of CN128 in Thalassemia Patients
NCT04614779 ·Status: COMPLETED ·Phase: PHASE2
-
Iron Deficiency Anemia in Childern With Liver Cirrhosis
NCT03482076 ·Status: UNKNOWN ·Phase: NA
-
The Prevelence of IVS 1-6 (T-C) [HBB:c.92 +6 T-C] Gene Mutation in Suspected Cases of β Thalassemia in Assiut University Hospitals
NCT05370677 ·Status: UNKNOWN
-
Clinical Observation of Luspatercept in Treatment of Chinese Adult β-thalassaemia Patients With TD β-thalassemia
NCT06164821 ·Status: RECRUITING ·Phase: NA
-
Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
NCT00972231 ·Status: COMPLETED